Celltrion
068270.KS
#814
Rank
โ‚น2.570 T
Marketcap
โ‚น11,429
Share price
2.07%
Change (1 day)
20.36%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น90.55

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น96.20. In 2023 the company made an earnings per share (EPS) of โ‚น248.80 a decrease over its 2022 EPS that were of โ‚น254.08.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น90.55
2023โ‚น248.80-2.08%
2022โ‚น254.08-11.72%
2021โ‚น287.812.03%
2020โ‚น282.0782.8%
2019โ‚น154.3018.31%
2018โ‚น130.42-36.33%
2017โ‚น204.86161.25%
2016โ‚น78.412.86%
2015โ‚น76.2317.84%
2014โ‚น64.695.87%
2013โ‚น61.10-70.85%
2012โ‚น209.62134.09%
2011โ‚น89.5543.59%
2010โ‚น62.3674.49%
2009โ‚น35.74317.8%
2008โ‚น8.55-71.7%
2007โ‚น30.23